Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

New genetic associations detected in a host response study to hepatitis B vaccine.

Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M.

Genes Immun. 2010 Apr;11(3):232-8. doi: 10.1038/gene.2010.1. Epub 2010 Mar 18.

PMID:
20237496
2.

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC.

J Med Virol. 2001 Jul;64(3):290-8.

PMID:
11424117
4.

Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).

Azarkeivan A, Karimi G, Shaiegan M, Maghsudlu M, Tabbaroki A.

Pediatr Hematol Oncol. 2009 Jun;26(4):195-201. doi: 10.1080/08880010902895900.

PMID:
19437322
5.

Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.

Cardell K, Akerlind B, Sällberg M, Frydén A.

J Infect Dis. 2008 Aug 1;198(3):299-304. doi: 10.1086/589722.

PMID:
18544037
6.

Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.

Höhler T, Groeger-Bicanic G, Hoet B, Stoffel M.

Vaccine. 2007 Feb 9;25(8):1503-8. Epub 2006 Oct 27.

PMID:
17097774
7.

Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.

McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.

J Infect Dis. 2009 Nov 1;200(9):1390-6. doi: 10.1086/606119.

PMID:
19785526
8.

Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents.

Wu TW, Chu CC, Ho TY, Chang Liao HW, Lin SK, Lin M, Lin HH, Wang LY.

Hum Genet. 2013 Oct;132(10):1131-9. doi: 10.1007/s00439-013-1320-5. Epub 2013 Jun 6.

PMID:
23739870
9.

Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.

Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.

Z Gastroenterol. 2003 Oct;41(10):983-90.

PMID:
14562195
10.

No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.

Belloni C, Avanzini MA, De Silvestri A, Martinetti M, Pasi A, Coslovich E, Autelli M, Masanti ML, Cuccia M, Tinelli C, Rondini G, Lorini R.

Pediatrics. 2002 Jul;110(1 Pt 1):e4.

PMID:
12093985
11.

Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination.

Sleijffers A, Yucesoy B, Kashon M, Garssen J, De Gruijl FR, Boland GJ, Van Hattum J, Luster MI, Van Loveren H.

J Immunol. 2003 Mar 15;170(6):3423-8.

12.

Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.

Jafarzadeh A, Montazerifar SJ.

J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):4-9.

PMID:
17591001
13.

HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.

Lin HH, Liao HW, Lin SK, Wang LY.

Vaccine. 2008 Jun 25;26(27-28):3414-20. doi: 10.1016/j.vaccine.2008.04.038. Epub 2008 May 5.

PMID:
18501999
14.

Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.

Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH.

Pediatrics. 1999 Feb;103(2):E14.

PMID:
9925860
15.

Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine.

McDermott AB, Cohen SB, Zuckerman JN, Madrigal JA.

Vaccine. 1999 Jan 28;17(4):330-9.

PMID:
9987171
16.

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.

Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN.

Liver Transpl. 2001 Apr;7(4):314-20.

17.

Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.

Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D.

Clin Nephrol. 2007 Oct;68(4):228-34.

PMID:
17969490
18.

Hepatitis B vaccine nonresponse and celiac disease.

Noh KW, Poland GA, Murray JA.

Am J Gastroenterol. 2003 Oct;98(10):2289-92.

PMID:
14572581
19.

Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination.

Castellanos M, Cinza Z, Dorta Z, Veliz G, Vega H, Lorenzo I, Ojeda S, Dueñas-Carrera S, Alvarez-Lajonchere L, Martínez G, Ferrer E, Limonta M, Linares M, Ruiz O, Acevedo B, Torres D, Márquez G, Herrera L, Arús E.

J Gene Med. 2010 Jan;12(1):107-16. doi: 10.1002/jgm.1407.

PMID:
19866482
20.

[Efficacy of vaccination against hepatitis B in adult with HIV infection].

Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T.

Przegl Epidemiol. 2007;61(2):339-47. Polish.

PMID:
17956052

Supplemental Content

Support Center